Topics
CNS Tumors | Diagnosis | Magnetic resonance imaging | Treatment-Related Imaging Abnormality
Home > Publications > Topics > CNS Tumors > Diagnosis > Magnetic resonance imaging > Treatment-Related Imaging Abnormality
2026
Lauwens L, Zegers CML, Postma AA, Minniti G, Alapetite C,
Andratschke N, Berghoff A, Blomstrand M, Booth TC, Castellano A,
Chalmers AJ, Dankbaar JW, Delgado AF, Duerinck J, Ehret F, Erridge
SC, Franceschi E, Furtner J, Galldiks N, Harrabi SB, Høyer
M, Iannalfi A, Kazda T, Le Rhun E, Löbel U, Lombardi G,
Lütgendorf-Caucig C, Mankad K, Navarria P, Niyazi M, Nunes T,
Pons-Escoda A, Preusser M, Ramos A, Razis E, Roelofs E, Rudà
R, Savatovsky J, Sepúlveda JM, Sundgren PC, Timmermann B,
Troost EGC, Van der Hoorn A, Weber DC, Weller M, van den Bent MJ,
Lambrecht M, Smits M, Eekers DBP.
ESTRO,
ESNR and EORTC consensus-based definition for MRI abnormalities
after radiotherapy for intracranial central nervous system
tumours.
Neuro
Oncol. 2026 Aug 20:noag194. doi:
10.1093/neuonc/noag194. PMID:
42623110˰ ˍ